The strongest pathological correlate was global tau burden across all three cognitive domains which is congruent with the evidence that tau pathology is closely related to cognitive symptoms in both typical and atypical AD (Ossenkoppele et al., 2016; Xia et al., 2017; Tetzloff et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.